AzTrials
AzTrials

Brain TumorNCT04474678

Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!")

A study testing "My Logbook! - I know my way around!" in people with Brain Tumor and Neurofibromatoses, run by Medical University of Vienna at 22 sites in 4 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In this study, the main goal is to implement and evaluate a novel, evidence-based psycho-educative program for children in oncological care. Patients are provided with booklets tailored to each specific stage of their treatment. Among other factors, children's emotional well-being is evaluated as well as feasibility. Read more about this study

Who is it for?
Ages 6 to 14 years
Conditions the study is for
Brain Tumor, Neurofibromatoses, Sarcoma
What is being tested?
"My Logbook! - I know my way around!"
Could I receive a placebo?
No, everyone receives an active treatment
How many people
240 participants
Where
22 sitesin 4 countries
Study dates
7 Sep 2020to 31 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 14 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • currently or formerly treated for oncological condition
  • children/families at standard risk (Pediatric Psychosocial Preventative Health Model (PPPHM))
  • at least average cognitive abilities (as measured via intelligence test)
  • currently or formerly treated for oncological condition

Who cannot join

  • non-German speaking
  • Major vision impairments
  • Major auditive impairments

Trial locations and contacts

22 sites in 4 countries.

22 sites in 4 countries

Germany15 sites
  • Klinik Bad Oexen

    Bad Oeynhausen, 32549

  • Charité - Universitätsmedizin Berlin

    Berlin

  • Luca-Dethlefsen-Hilfe e.V.

    Bielefeld

  • Universitätsklinikum Carl Gustav Carus Dresden

    Dresden

  • Universitätsklinikum Essen

    Essen, North Rhine-Westphalia, 45147

  • Universitätsklinikum Frankfurt am Main

    Frankfurt am Main, Hesse, 60590

  • Universitätsklinikum Hamburg-Eppendorf

    Hamburg

  • Medizinische Hochschule Hannover

    Hanover, Lower Saxony, 30625

  • Universitätsklinikum des Saarlandes

    Homburg, Saarland, 66421

  • Universitätsklinikum Leipzig

    Leipzig, Saxony, 04103

  • Universitätsklinikum Mannheim

    Mannheim

  • Universitätsklinikum Münster

    Münster, North Rhine-Westphalia, 48149

  • Universitätsklinikum Regensburg

    Regensburg

  • Universitätsklinikum Tübingen

    Tübingen

  • Universitätsklinikum Würzburg

    Würzburg

Other trials in Germany

Austria5 sites
  • Medical University Graz

    Graz

  • Kepler Universitätsklinikum

    Linz, Upper Austria, 4021

  • Rehabilitationszentrum St. Veit im Pongau

    Sankt Veit im Pongau, State of Salzburg, 5621

  • Medical University of Vienna

    Vienna, 1090

  • St. Anna Kinderspital

    Vienna, 1090

Other trials in Austria

Italy1 site
  • Ospedale di Bolzano

    Bolzano, Trentino-Alto Adige, 39100

Other trials in Italy

Switzerland1 site
  • Inselspital, Universitätsspital Bern

    Bern

Other trials in Switzerland

About this study

Official title: A Quality Improvement Project to Implement Psychosocial Care Standards in Clinical Practice in Pediatric Oncology "My Logbook! - I Know my Way Around!" ("Mein Logbuch - Ich Kenne Mich Aus!") Development and Evaluation of a Consensus and Evidence Based Psychosocial Therapy Tool in a Preliminary Psychosocial Study on Therapy Optimization.

In this study, the main goal is to implement and evaluate a novel, evidence-based psycho-educative program for children in oncological care. Patients are provided with booklets tailored to each specific stage of their treatment. Among other factors, children's emotional well-being is evaluated as well as feasibility. The study is carried out at multiple sites across Austria, Germany and Italy/South Tirol.

Read the detailed description

It is well documented that the prevalence of mental disorders in childhood cancer survivors is twice to quadruple compared to healthy controls. Effects range from impaired emotional balance, fear of recidivisms, helplessness, depression to post traumatic stress disorder.

As a basis for interventions to preventively address these issues and moreover, to achieve defined psychosocial goals in the field of paediatric oncology, guidelines and standards systematically describe stressors and resources in particularly challenging situations. Nevertheless, despite these guidelines, actual care is quite heterogenous due to differences in setting, provision and profession. Studies show that integrated models of psychosocial care yield better outcomes. Integrated care systems can enhance patient satisfaction, increase perceived quality of care, and enable access to services and reduce service costs. Highly complex, system-wide interventions such as models of integrated care represent considerable challenges for operationalisation of relevant factors and evaluation of whole processes compared to single interventions (e.g. relaxation techniques). Quality improvement (QI) is an iterative process designed to make controlled changes within the health care delivery system to provide patients with high-quality care that meets both their expectations and needs. In terms of quality assurance, this QI Project aims to operationalize recommendations of the S3 guideline for psychosocial care which results in a combined process- and patient-oriented intervention and evaluation tool - bridging the gap between standards/evidence and clinical practice.

The "Onco-Mini-Version" of "My Logbook - I know my way around" already comprises a Starter-Kit and 8 booklets, which cover at least one main issue of every treatment phase: initial contact, medical assessment (MRI), supportive therapy (chemotherapy, radio therapy), rehabilitation and after-care. All interventions are carried out by a clinical psychologist or psychosocial staff specialized in pediatric psychooncology and are understood as part of an integrated care system. Every booklet provides practical materials with enhanced stimulating elements to encourage the child to explore actively. The booklets are structured in two face-to-face sessions covering psychoeducational, activity \& practice and reflective aspects.

The core of this QI project is a multilevel and interdisciplinary approach characterized by iterative processes. PDSA (Plan, Do, Study, Act) cycles were applied in all steps of conceptualization and implementation of this project. It aims to systematically improve psychosocial care of pediatric cancer patients through being implemented in a large number of hospitals in the German-speaking world. The proposed multicenter pilot phase promotes emotional well-being and level of information of the child during treatment through transfer of knowledge and coping skills. Moreover, it addresses feasibility of the tool but also the impact of medical procedures on feasibility. In the long term, the program is intended to help attenuate psychological late effects of oncological conditions and their treatments.

Being tested
"My Logbook! - I know my way around!"
Medical subject headings
Brain Neoplasms, Neurofibromatoses, Sarcoma, Leukemia, Hematologic Diseases, Neuroblastoma

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • "My Logbook! - I know my way around!"Other

    Special issues/booklets of "My Logbook - I know my way around!" - Every booklet is based on evidence-based interventions. It illustrates psychosocial and interdisciplinary processes in a standardized way, resulting in a practical guide ("My Logbook") to accompany the child throughout all stages of oncological treatment.

Study groups in NCT04474678
Study groupRoleWhat they receive
All PatientsOtherSince this is a single-group study, all patients are within the same arm
Receives: Other: "My Logbook! - I know my way around!"

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Emotional well-being, T1

    Patients' emotional well-being is evaluated using a visual array of emotional displays. Patients can choose three emotions that describe their current situation best. For analysis, emotions are categorized into positive, neutral, and negative emotions. Emotional well-being is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house, publication is pending.

    Measured: Based on the medical therapy protocol, after medical consultation, prior to first session of the special issue (booklet) - through study completion or end of medical treatment, an average of 1 year

  2. Emotional well-being, T2

    Patients' emotional well-being is evaluated using a visual array of emotional displays. Patients can choose three emotions that describe their current situation best. For analysis, emotions are categorized into positive, neutral, and negative emotions. Emotional well-being is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house, publication is pending.

    Measured: Post to first session of the special issue (booklet) - through study completion or end of medical treatment, an average of 1 year

  3. Emotional well-being, T3

    Patients' emotional well-being is evaluated using a visual array of emotional displays. Patients can choose three emotions that describe their current situation best. For analysis, emotions are categorized into positive, neutral, and negative emotions. Emotional well-being is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house, publication is pending.

    Measured: During, but before completion of treatment; prior to second session of the special issue (booklet) - through study completion or end of medical treatment, an average of 1 year

  4. Emotional well-being, T4

    Patients' emotional well-being is evaluated using a visual array of emotional displays. Patients can choose three emotions that describe their current situation best. For analysis, emotions are categorized into positive, neutral, and negative emotions. Emotional well-being is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house, publication is pending.

    Measured: During, post to second session of the special issue (booklet) - through study completion or end of medical treatment, an average of 1 year

  5. Emotional well-being, T5

    Patients' emotional well-being is evaluated using a visual array of emotional displays. Patients can choose three emotions that describe their current situation best. For analysis, emotions are categorized into positive, neutral, and negative emotions. Emotional well-being is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house, publication is pending.

    Measured: During, but before completion of treatment - through study completion or end of medical treatment, an average of 1 year

  6. Knowledgeability, T1

    Patients are asked to rate their own knowledgeability regarding treatment, illness and hospital environment on a five-point scale ranging from "beginner" to "expert". Knowledgeability is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house.

    Measured: Based on the medical therapy protocol, after medical consultation, prior to first session of the special issue (booklet) - through study completion or end of medical treatment, an average of 1 year

  7. Knowledgeability, T2

    Patients are asked to rate their own knowledgeability regarding treatment, illness and hospital environment on a five-point scale ranging from "beginner" to "expert". Knowledgeability is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house.

    Measured: Post to first session of the special issue (booklet) - through study completion or end of medical treatment, an average of 1 year

  8. Knowledgeability, T3

    Patients are asked to rate their own knowledgeability regarding treatment, illness and hospital environment on a five-point scale ranging from "beginner" to "expert". Knowledgeability is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house.

    Measured: During, but before completion of treatment; prior to second session of the special issue (booklet) - through study completion or end of medical treatment, an average of 1 year

  9. Knowledgeability, T4

    Patients are asked to rate their own knowledgeability regarding treatment, illness and hospital environment on a five-point scale ranging from "beginner" to "expert". Knowledgeability is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house.

    Measured: During, post to second session of the special issue (booklet) - through study completion or end of medical treatment, an average of 1 year

  10. Knowledgeability, T5

    Patients are asked to rate their own knowledgeability regarding treatment, illness and hospital environment on a five-point scale ranging from "beginner" to "expert". Knowledgeability is evaluated longitudinally over multiple points of time. The diagnostic tool was developed in-house.

    Measured: During, but before completion of treatment - through study completion or end of medical treatment, an average of 1 year

  11. Feasibility of program

    Rating of feasibility of the program by medical staff

    Measured: Feasibility of program is evaluated following the second session which on average takes place one to six months after start of the treatment of the special issue (booklet). - through study completion or end of medical treatment, an average of 1 year

Secondary outcomes (6)
  1. Intelligence test

    Patients are administered a standardized intelligence test, dependent on their age, e.g.

    Wechsler Intelligence Scale for Children IV WISC-IV, Petermann \& Petermann, 2014 or other comparable methods due to clinical standards

    Measured: During the first two months from diagnosis or start of psychosocial treatment - up to three Months

  2. Strengths and Difficulties Questionnaire (SDQ; Goodman, 1999)

    The Strengths and Difficulties Questionnaire (SDQ) is a brief behavioural screening questionnaire about 3-16 year olds.

    Measured: During the first two months from diagnosis or start of psychosocial treatment - up to three Months

  3. KINDLR (Ravens-Sieberer & Bullinger, 2000)

    The KINDLR is a standardized questionnaire for the assessment of quality of life in children and adolescents.

    Measured: During the first two months from diagnosis or start of psychosocial treatment - up to three Months

  4. Questionnaire on Health Competence in Children and Adolescents, (Weiler, Fohn, Pletschko, Schwarzinger, & Leiss, 2017)

    Questionnaire for the assessment of health competence in children and adolescents

    Measured: During the first two months from diagnosis or start of psychosocial treatment - up to three Months

  5. Medical information

    Diagnosis, date of diagnosis, pre-existing conditions, secondary conditions, form of treatment/therapy, psychiatric diagnoses, neurological status

    Measured: Within the first week of treatment - up to three Months

  6. Demographic data

    Age of patient, sex, parents' education, parents' profession, school form, mother language of patient

    Measured: During the first two months from diagnosis or start of psychosocial treatment - up to three Months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jul 2020
  2. Study start7 Sep 2020
  3. Primary completion31 Dec 2023
  4. Study completion31 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
240 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04474678
Sponsor's protocol ID
1564/2017
Status last verified
Jan 2024
First submitted
23 Jun 2020
Last updated
9 Jan 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Kazak AE, Abrams AN, Banks J, Christofferson J, DiDonato S, Grootenhuis MA, Kabour M, Madan-Swain A, Patel SK, Zadeh S, Kupst MJ. Psychosocial Assessment as a Standard of Care in Pediatric Cancer. Pediatr Blood Cancer. 2015 Dec;62 Suppl 5:S426-59. doi: 10.1002/pbc.25730.

    PubMed 26700916
  • Scialla MA, Canter KS, Chen FF, Kolb EA, Sandler E, Wiener L, Kazak AE. Delivery of care consistent with the psychosocial standards in pediatric cancer: Current practices in the United States. Pediatr Blood Cancer. 2018 Mar;65(3):10.1002/pbc.26869. doi: 10.1002/pbc.26869. Epub 2017 Oct 28.

    PubMed 29080381
  • Baxter S, Johnson M, Chambers D, Sutton A, Goyder E, Booth A. The effects of integrated care: a systematic review of UK and international evidence. BMC Health Serv Res. 2018 May 10;18(1):350. doi: 10.1186/s12913-018-3161-3.

    PubMed 29747651
  • Schurman JV, Gayes LA, Slosky L, Hunter ME, Pino FA. Publishing quality improvement work in Clinical Practice in Pediatric Psychology: The "why" and "how to". Clinical Practice in Pediatric Psychology. 2015 Mar; 3(1):80.

  • Schreiber-Gollwitzer BM, Schroder HM, Griessmeier B, Labouvie H, Lilienthal S; PSAPOH. [Quantitative and qualitative evaluation of psychosocial care for patients in pediatric oncology and hematology--a multicenter study on behalf of the PSAPOH]. Klin Padiatr. 2003 May-Jun;215(3):171-6. doi: 10.1055/s-2003-39377. German.

    PubMed 12778358
  • Stuber ML, Meeske KA, Krull KR, Leisenring W, Stratton K, Kazak AE, Huber M, Zebrack B, Uijtdehaage SH, Mertens AC, Robison LL, Zeltzer LK. Prevalence and predictors of posttraumatic stress disorder in adult survivors of childhood cancer. Pediatrics. 2010 May;125(5):e1124-34. doi: 10.1542/peds.2009-2308.

    PubMed 20435702
  • Koch U, Mehnert A, Harter M. [Chronic somatic disorders and psychological comorbidity]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2011 Jan;54(1):1-3. doi: 10.1007/s00103-010-1196-7. No abstract available. German.

    PubMed 21246321
  • Weiler-Wichtl LJ, Fohn-Erhold V, Rosenmayr V, Hansl R, Hopfgartner M, Fries J, Schneider C, Herzog K, Neumann K, Schellenberg T, Schonenberger-Loppacher D, Faist-Schweika C, Schonthaler B, Stember N, Wiegele K, Reddig M, Paduch A, Lein-Kohler I, Hoffmann R, Kollmann A, Just U, Salzmann N, Gerhardt M, Essl S, Borbely J, Kopper M, Pal-Handl K, Wasinger-Brandweiner V, Rinner S, Schubert L, Lange S, Leiss U. "MyLogbook-I Know My Way Around": A Psychological Therapy Program to Enhance Health Literacy and Positive Emotional Adjustment in Pediatric Oncology. Psychooncology. 2026 Aug;35(8):e70577. doi: 10.1002/pon.70577.

    PubMed 42631525
  • Weiler-Wichtl LJ, Fohn-Erhold V, Rosenmayr V, Hansl R, Hopfgartner M, Pal-Handl K, Wasinger-Brandweiner V, Herzog K, Neumann K, Schellenberg T, Schonenberger-Loppacher D, Faist-Schweika C, Schonthaler B, Budich M, Stember N, Wiegele K, Reddig M, Paduch A, Lein-Kohler I, Gorgen S, Wienands H, Gauf H, Hoffmann R, Kollmann A, Just U, Salzmann N, Neunsinger P, Gerhardt M, Essl S, Borbely J, Kopper M, Rinner S, Schubert L, Leiss U. Benefits of applying standardized frameworks to implement psychosocial tools such as the 'My Logbook'. Support Care Cancer. 2024 Nov 14;32(12):789. doi: 10.1007/s00520-024-08981-7.

    PubMed 39538073
  • Weiler-Wichtl LJ, Fohn-Erhold V, Rosenmayr V, Hansl R, Hopfgartner M, Fries J, Schneider C, Herzog K, Schellenberg T, Schonthaler B, Stember N, Lein-Kohler I, Hoffmann R, Kollmann A, Salzmann N, Essl S, Pal-Handl K, Wasinger-Brandweiner V, Rinner S, Schubert L, Lange S, Leiss U. Preparing Children for Invasive Medical Cancer Treatment with "My Logbook": Preliminary Results of a Pilot Study. J Cancer Educ. 2025 Feb;40(1):132-141. doi: 10.1007/s13187-024-02481-2. Epub 2024 Aug 7.

    PubMed 39107671

Questions about this trial

What is this clinical trial studying?

A study testing "My Logbook! - I know my way around!" in people with Brain Tumor and Neurofibromatoses, run by Medical University of Vienna at 22 sites in 4 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 22 sites in Germany, Austria, Italy, Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Emotional well-being, T1 (time frame: Based on the medical therapy protocol, after medical consultation, prior to first session of the special issue (booklet) - through study completion or end of medical treatment, an average of 1 year). The study lists 11 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04474678, which also lists 10 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in